Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies

OBJECTIVES: Lipid profiles are altered by active disease in patients with rheumatoid arthritis (RA) and may be further modified by treatment with Janus kinase inhibitors and other disease-modifying antirheumatic drugs. METHODS: Lipid data were analysed from phase II and III studies of 4 mg (n=997) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C, Kremer, Joel M, Emery, Paul, Zuckerman, Steven H, Ruotolo, Giacomo, Zhong, Jinglin, Chen, Lei, Witt, Sarah, Saifan, Chadi, Kurzawa, Monika, Otvos, James D, Connelly, Margery A, Macias, William L, Schlichting, Douglas E, Rooney, Terence P, de Bono, Stephanie, McInnes, Iain B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029633/
https://www.ncbi.nlm.nih.gov/pubmed/29463520
http://dx.doi.org/10.1136/annrheumdis-2017-212461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029633/
https://www.ncbi.nlm.nih.gov/pubmed/29463520
http://dx.doi.org/10.1136/annrheumdis-2017-212461

Ejemplares similares